RSWM
CUE icon

Robertson Stephens Wealth Management’s Cue Biopharma CUE Stock Holding History

Robertson Stephens Wealth Management’s Portfolio CUE Stock Details CUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$351K Sell
11,133
-4,817
-30% -$109K 0.01% 493
2026
Q1 		$110K Hold
15,950
– – ﹤0.01% 597
2025
Q4 		$146K Hold
15,950
– – ﹤0.01% 614
2025
Q3 		$344K Hold
15,950
– – 0.01% 423
2025
Q2 		$326K Hold
15,950
– – 0.01% 440
2025
Q1 		$436K Hold
15,950
– – 0.02% 386
2024
Q4 		$522K Hold
15,950
– – 0.02% 352
2024
Q3 		$362K Hold
15,950
– – 0.01% 492
2024
Q2 		$593K Hold
15,950
– – 0.03% 306
2024
Q1 		$904K Hold
15,950
– – 0.05% 248
2023
Q4 		$1.26M Hold
15,950
– – 0.08% 199
2023
Q3 		$1.1M Hold
15,950
– – 0.07% 195
2023
Q2 		$1.75M Hold
15,950
– – 0.12% 142
2023
Q1 		$1.71M Hold
15,950
– – 0.13% 142
2022
Q4 		$1.36M Hold
15,950
– – 0.13% 148
2022
Q3 		$1.07M Hold
15,950
– – 0.11% 147
2022
Q2 		$1.19M Hold
15,950
– – 0.11% 144
2022
Q1 		$2.33M Hold
15,950
– – 0.2% 97
2021
Q4 		$5.41M Hold
15,950
– – 0.46% 47
2021
Q3 		$6.97M Hold
15,950
– – 0.79% 29
2021
Q2 		$5.57M Hold
15,950
– – 0.67% 33
2021
Q1 		$5.84M Sell
15,950
-183
-1% -$75.3K 0.93% 24
2020
Q4 		$6.05M Hold
16,133
– – 1.27% 19
2020
Q3 		$7.28M Buy
+16,133
New +$9.3M 1.79% 14

Other funds holding CUE

BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
TAM
TFG Asset Management Grand Cayman, Cayman Islands $635M AUM 28.07% 1-Year Est. Return
SC
Stempoint Capital New York $581M AUM 373.68% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
LPC
Lion Point Capital New York $20.9M AUM 195.52% 1-Year Est. Return
SCM
Squadron Capital Management Westmont, Illinois $322M AUM

Robertson Stephens Wealth Management's CUE Position: Q2 2026 in Review

Robertson Stephens Wealth Management reduced its Cue Biopharma (CUE) stake by 30% in Q2 2026, selling an estimated $109K and leaving 11,133 shares worth $351K. The position accounts for 0.01% of the portfolio, ranked #493.

Robertson Stephens Wealth Management first reported a position in CUE in Q3 2020 and has held it in 24 quarters since. The position peaked at $7.28M in Q3 2020. 49 funds tracked by Wall St. Rank hold CUE as of Q2 2026.

  • Robertson Stephens Wealth Management held 11,133 shares of Cue Biopharma worth $351K as of Q2 2026.
  • Robertson Stephens Wealth Management sold 4,817 Cue Biopharma shares in Q2 2026, an estimated $109K.
  • Cue Biopharma made up 0.01% of Robertson Stephens Wealth Management's portfolio in Q2 2026, its #493 holding.
  • Robertson Stephens Wealth Management first reported a position in Cue Biopharma in Q3 2020 and has held it in 24 quarters since.
  • Robertson Stephens Wealth Management's Cue Biopharma position peaked at $7.28M in Q3 2020.
  • 49 funds tracked by Wall St. Rank held Cue Biopharma as of Q2 2026.

Based on Robertson Stephens Wealth Management's 13F filing for Q2 2026, filed 29 Jul 2026.